Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A

7(70.0%)

Phase 4

2(20.0%)

Phase 2

1(10.0%)

10Total

N/A(7)

Phase 4(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT05380661Not ApplicableCompleted

Heart Rate Variability and Anxiety During Urinary Bladder Catheterization

Role: collaborator

NCT07212725Not ApplicableCompleted

Solving SCI Pain: Pain Recovery Tools for SCI

Role: collaborator

NCT06838637Not ApplicableRecruiting

Transcutaneous Spinal Cord Stimulation Home Study

Role: collaborator

NCT03111030Not ApplicableCompleted

ProACTIVE SCI Physical Activity Intervention

Role: collaborator

NCT04604951Not ApplicableRecruiting

Below the Belt: Non-invasive Neuromodulation to Treat Bladder, Bowel, and Sexual Dysfunction Following Spinal Cord Injury

Role: collaborator

NCT03179475Phase 4Completed

Targin® for Chronic Pain Management in Patients With Spinal Cord Injury

Role: collaborator

NCT05003999Not ApplicableCompleted

Time Needed to Perform Intermittent Catheterization in Adults With Spinal Cord Injuries

Role: collaborator

NCT02298660Phase 4Completed

Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCI

Role: collaborator

NCT03924388Not ApplicableUnknown

Spinal Cord Stimulation and Autonomic Response in People With SCI.

Role: collaborator

NCT02676154Phase 2Completed

Fesoterodine for Amelioration of Autonomic Dysreflexia (AD) Following Spinal Cord Injury (SCI)

Role: collaborator

All 10 trials loaded